These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6325330

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Specific binding of phospholipid platelet-activating factor by human platelets.
    Valone FH, Coles E, Reinhold VR, Goetzl EJ.
    J Immunol; 1982 Oct; 129(4):1637-41. PubMed ID: 6286773
    [Abstract] [Full Text] [Related]

  • 3. Modulation of cytoplasmic calcium in human platelets by the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.
    Valone FH, Johnson B.
    J Immunol; 1985 Feb; 134(2):1120-4. PubMed ID: 2578151
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Purification and characterization of the specific binding protein for platelet activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) from human platelets.
    Nishihira J, Ishibashi T, Imai Y, Muramatsu T.
    Tohoku J Exp Med; 1985 Oct; 147(2):145-52. PubMed ID: 3001971
    [Abstract] [Full Text] [Related]

  • 6. Enhancement of human polymorphonuclear leukocyte adherence by the phospholipid mediator 1-O-hexadecyl-2-acetyl-sn-glycero-3-phosphorylcholine (AGEPC).
    Valone FH, Goetzl EJ.
    Am J Pathol; 1983 Oct; 113(1):85-9. PubMed ID: 6624880
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Decay of the activating signal after platelet stimulation with 1-0-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine: changes in calcium permeability.
    Valone FH, Johnson B.
    Thromb Res; 1985 Nov 01; 40(3):385-92. PubMed ID: 4082115
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulation of the surface expression of the platelet-activating factor receptor in IC-21 peritoneal macrophages. Effects of lipopolysaccharide.
    Liu H, Chao W, Olson MS.
    J Biol Chem; 1992 Oct 15; 267(29):20811-9. PubMed ID: 1328211
    [Abstract] [Full Text] [Related]

  • 17. Identification of receptors for platelet-activating factor in rat Kupffer cells.
    Chao W, Liu H, DeBuysere M, Hanahan DJ, Olson MS.
    J Biol Chem; 1989 Aug 15; 264(23):13591-8. PubMed ID: 2547767
    [Abstract] [Full Text] [Related]

  • 18. Binding and metabolism of platelet-activating factor by human neutrophils.
    O'Flaherty JT, Surles JR, Redman J, Jacobson D, Piantadosi C, Wykle RL.
    J Clin Invest; 1986 Aug 15; 78(2):381-8. PubMed ID: 3016027
    [Abstract] [Full Text] [Related]

  • 19. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
    Macconi D, Morzenti G, Livio M, Morelli C, Cassina G, Remuzzi G.
    Lab Invest; 1985 Feb 15; 52(2):159-68. PubMed ID: 3155816
    [Abstract] [Full Text] [Related]

  • 20. Metabolic behavior of acetyl glyceryl ether phosphorylcholine on interaction with rabbit platelets.
    Pieroni G, Hanahan DJ.
    Arch Biochem Biophys; 1983 Jul 15; 224(2):485-93. PubMed ID: 6870274
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.